Series A

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

A new oral drug candidate for lupus and RA emerges as Totus Medicines uses its AI platform to rapidly develop a first-in-class inhibitor for the elusive IRF5 protein.

Deep-tech firm AHOY surpasses $100M ARR with its "Real-World AI," now seeking major funding to expand its sovereign AI for critical infrastructure.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.

New platform promises to discover every AI workflow, measure its true business impact, and give leaders control over rampant shadow AI adoption.

A luxury brand and an NGO award women in bio-tech and MedTech, tackling the stark funding gap and championing a new generation of impact-driven founders.

As Ontario hospitals face a financial crisis, a major innovation week aims to connect Canadian startups with global capital to solve healthcare's biggest challenges.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

With a fresh $12M in funding, Canadian fintech Common Wealth is using AI and a modern platform to bring retirement plans to underserved small businesses.

A high-level visit to General Atomics signals a major U.S. push for fusion energy, blending private innovation with public funding to win a global race.

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

A new company is selling franchises to doctors and pharmacists, promising to cut out insurers and restore local care. But can this bold model survive the system?

Five new clinical trials in Chicago repurpose existing drugs for PTSD, cancer, and more, offering a faster, cheaper path to treating unsolved diseases.

Brands are disappearing from new AI search engines. A new discipline called 'Machine Relations' aims to solve this 'AI invisibility' crisis.

Evaline Tsai's promotion at Gigascale Capital highlights a new VC playbook where deep scientific expertise is crucial for funding our physical economy's future.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

Ann Arbor startup Adrenaline Interactive lands a $1M prize to revolutionize in-game ads, signaling Michigan's push to become a tech innovation hub.

A small environmental firm unveils a plan to upend global markets with a fraud-proof 'Physical Truth Infrastructure.' But can it deliver on its promises?

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.